Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02574273 · ClinicalTrials.gov registry record · NA

Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)

A NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD), sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT02574273 is a NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD) that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 106 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02574273, a NA study of Anxiety and Attention Deficit Hyperactivity Disorder (ADHD), has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont \& Sofronoff, 2008; Tan, Mazzucchelli \& Beaumont, submitted), school-(Beaumont, Rotolone \& Sofronoff, in press; Einfeld et al., submitted) and remote Skype/telephone-assisted delivery contexts (Sofronoff, Silva \& Beaumont, in press).The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder.

Interventions

  • BEHAVIORAL Secret Agent Society (SAS) Program
  • OTHER Waitlist Group / Treatment As Usual

Study Locations (1)

New York

  • Weill Cornell Medical College - New York

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2015-10
Est. Completion 2018-12
Phase NA

What the Registry Record Tells You About NCT02574273

The ClinicalTrials.gov registry entry for NCT02574273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (76% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Secret Agent Society (SAS) Program is the first listed.

NCT02574273 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02574273 about?

NCT02574273 is a clinical study titled "Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)". Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont \& Sofronoff, 2008; Tan, Mazzucchelli \& Beaumont, submitted), school-(Beaumo...

What is the current status of trial NCT02574273?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2015-10. Estimated completion is 2018-12.

What conditions does trial NCT02574273 study?

This clinical trial studies the following conditions: Anxiety, Attention Deficit Hyperactivity Disorder (ADHD), Autistic Spectrum Disorder (ASD).

What interventions are being tested in trial NCT02574273?

The interventions under investigation include: Secret Agent Society (SAS) Program (BEHAVIORAL), Waitlist Group / Treatment As Usual (OTHER).

Who is sponsoring clinical trial NCT02574273?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02574273 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.